Karina Vera

2.2k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Karina Vera is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, Karina Vera has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Transplantation. Recurrent topics in Karina Vera's work include Renal Transplantation Outcomes and Treatments (5 papers), Organ Donation and Transplantation (4 papers) and Colorectal Cancer Treatments and Studies (2 papers). Karina Vera is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Organ Donation and Transplantation (4 papers) and Colorectal Cancer Treatments and Studies (2 papers). Karina Vera collaborates with scholars based in United States, Argentina and France. Karina Vera's co-authors include Éric Raymond, Sandrine Faivre, Jean‐Pierre Armand, Catherine Delbaldo, Nicoletta Brega, P. Scigalla, Carlo L. Bello, Caroline Robert, Nathalie Lassau and Samuel E. DePrimo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Karina Vera

16 papers receiving 1.7k citations

Hit Papers

Safety, Pharmacokinetic, and Antitumor Activity of SU1124... 2005 2026 2012 2019 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karina Vera United States 10 816 762 723 287 158 17 1.7k
Katherine Liau United States 19 861 1.1× 843 1.1× 1.1k 1.5× 441 1.5× 122 0.8× 36 2.0k
Jeffrey P. Hodge United States 20 794 1.0× 566 0.7× 1.3k 1.7× 246 0.9× 203 1.3× 39 2.3k
Christian Rothermundt Switzerland 25 755 0.9× 971 1.3× 1.0k 1.4× 371 1.3× 285 1.8× 79 2.3k
Ana C. Xavier United States 13 518 0.6× 1.1k 1.5× 1.1k 1.5× 333 1.2× 82 0.5× 51 1.8k
Mayu Yunokawa Japan 25 511 0.6× 482 0.6× 1.1k 1.5× 373 1.3× 79 0.5× 140 2.1k
Emily Dunn United States 13 741 0.9× 492 0.6× 873 1.2× 220 0.8× 54 0.3× 24 1.7k
Francesco Schettini Italy 22 493 0.6× 641 0.8× 861 1.2× 463 1.6× 255 1.6× 113 2.0k
Nicoletta Brega United States 16 995 1.2× 804 1.1× 825 1.1× 301 1.0× 601 3.8× 52 2.1k
Panos Fidias United States 25 925 1.1× 1.8k 2.4× 1.7k 2.4× 276 1.0× 105 0.7× 58 3.0k
Juergen Wolf Germany 22 630 0.8× 914 1.2× 1.0k 1.4× 282 1.0× 48 0.3× 92 1.8k

Countries citing papers authored by Karina Vera

Since Specialization
Citations

This map shows the geographic impact of Karina Vera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karina Vera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karina Vera more than expected).

Fields of papers citing papers by Karina Vera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karina Vera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karina Vera. The network helps show where Karina Vera may publish in the future.

Co-authorship network of co-authors of Karina Vera

This figure shows the co-authorship network connecting the top 25 collaborators of Karina Vera. A scholar is included among the top collaborators of Karina Vera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karina Vera. Karina Vera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mark, Adam, Jessica Pham, Karina Vera, et al.. (2024). RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection. PLoS ONE. 19(8). e0307450–e0307450. 3 indexed citations
2.
Vera, Karina, et al.. (2022). Representaciones de estándares de belleza en profesionales de la salud que atienden mujeres Chilenas Diagnosticadas con trastorno de la conducta alimentaria. Revista Mexicana de Trastornos Alimentarios/Mexican Journal of Eating Disorders. 12(1). 25–38. 2 indexed citations
3.
Romero, Alfredo, et al.. (2022). Miocardiopatía por estrés asociada a quimioterapia. 24(1).
6.
Gordon, Elisa J., Min‐Woong Sohn, Chih‐Hung Chang, et al.. (2016). Effect of a Mobile Web App on Kidney Transplant Candidates' Knowledge About Increased Risk Donor Kidneys. Transplantation. 101(6). 1167–1176. 29 indexed citations
7.
Gordon, Elisa J., Joe Feinglass, Paula Carney, et al.. (2016). A Website Intervention to Increase Knowledge About Living Kidney Donation and Transplantation Among Hispanic/Latino Dialysis Patients. Progress in Transplantation. 26(1). 82–91. 45 indexed citations
8.
Gordon, Elisa J., Joe Feinglass, Paula Carney, et al.. (2015). A Culturally Targeted Website for Hispanics/Latinos About Living Kidney Donation and Transplantation. Transplantation. 100(5). 1149–1160. 64 indexed citations
9.
Feinglass, Joe, Karina Vera, Paula Carney, et al.. (2014). A Website for Hispanics/Latinos About Living Donation and Transplantation: A Randomized Controlled Trial of Increased Knowledge.. Transplantation. 98. 479–479. 4 indexed citations
10.
Gordon, Elisa J., Karina Vera, Min‐Woong Sohn, et al.. (2014). A Decision Aid for Kidney Transplant Candidates About Increased Risk Donor (IRD) Kidneys: A Randomized Controlled Trial of Increased Knowledge.. Transplantation. 98. 165–165. 3 indexed citations
11.
Tourneau, Christophe Le, Sandrine Faivre, Valérie Laurence, et al.. (2010). Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies. European Journal of Cancer. 46(18). 3243–3250. 131 indexed citations
12.
Denninghoff, Valeria, et al.. (2009). Preliminary report of the mutation status of KRAS and BRAF-V600E in an Argentinean population of primary colorectal tumors. Journal of Clinical Oncology. 27(15_suppl). e22183–e22183. 1 indexed citations
13.
Lyons, Gustavo, Sílvia Quadrelli, Carlos Silva, et al.. (2008). Analysis of Survival in 400 Surgically Resected Non-small Cell Lung Carcinomas: Towards a Redefinition of the T Factor. Journal of Thoracic Oncology. 3(9). 989–993. 9 indexed citations
14.
Delbaldo, Catherine, Éric Raymond, Karina Vera, et al.. (2007). Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors. Investigational New Drugs. 26(1). 35–43. 82 indexed citations
15.
Faivre, Sandrine, Catherine Delbaldo, Karina Vera, et al.. (2005). Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer. Journal of Clinical Oncology. 24(1). 25–35. 934 indexed citations breakdown →
16.
Raymond, Éric, Jérôme Alexandre, Sandrine Faivre, et al.. (2004). Safety and Pharmacokinetics of Escalated Doses of Weekly Intravenous Infusion of CCI-779, a Novel mTOR Inhibitor, in Patients With Cancer. Journal of Clinical Oncology. 22(12). 2336–2347. 398 indexed citations
17.
Vera, Karina, Sandrine Faivre, Jean Sébastien Guillamo, et al.. (2003). Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors. Annals of Oncology. 15(1). 161–171. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026